{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:04:55Z","timestamp":1790687095415,"version":"4.1.0"},"reference-count":195,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.humimm.2021.09.004","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T04:15:44Z","timestamp":1631074544000},"page":"86-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1128-5649","authenticated-orcid":false,"given":"Mehran","family":"Ghasemzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Ghasemzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6807-0908","authenticated-orcid":false,"given":"Ehteramolsadat","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"395","key":"10.1016\/j.humimm.2021.09.004_b0005","first-page":"514","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"2020","author":"Chan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2021.09.004_b0010","doi-asserted-by":"crossref","unstructured":"Frenkel LD, Gomez F, Bellanti JA: COVID-19 in children: Pathogenesis and current status. Allergy & Asthma Proceedings, vol 42, 2021.","DOI":"10.2500\/aap.2020.42.200104"},{"key":"10.1016\/j.humimm.2021.09.004_b0015","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-029736","article-title":"COVID-19 in children: looking forward, not back","volume":"147","author":"Lee","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.humimm.2021.09.004_b0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2021.09.004_b0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2021.09.004_b0030","doi-asserted-by":"crossref","unstructured":"M.D. Park, Macrophages: a Trojan horse in COVID-19?, Nature Publishing Group, 2020.","DOI":"10.1038\/s41577-020-0317-2"},{"key":"10.1016\/j.humimm.2021.09.004_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The Role of Cytokines including Interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.humimm.2021.09.004_b0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","article-title":"Biology of natural killer cells","volume":"47","author":"Trinchieri","year":"1989","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0045","series-title":"Williams Hematology","article-title":"Morphology of lymphocytes and plasma cells","author":"Baird","year":"2006"},{"key":"10.1016\/j.humimm.2021.09.004_b0050","series-title":"Williams Hematology","article-title":"Functions of natural killer cells","author":"Trinchieri","year":"2006"},{"key":"10.1016\/j.humimm.2021.09.004_b0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-2776(08)60033-4","article-title":"Cellular and humoral mechanisms of cytotoxicity: structural and functional analogies","volume":"41","author":"Young","year":"1987","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0060","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.4049\/jimmunol.130.5.2133","article-title":"Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1","volume":"130","author":"Perussia","year":"1983","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.22.012703.104711","article-title":"The dynamic life of natural killer cells","volume":"22","author":"Yokoyama","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0070","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4049\/jimmunol.172.3.1333","article-title":"NK cell compartments and their activation by dendritic cells","volume":"172","author":"Ferlazzo","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0075","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1189\/jlb.0304197","article-title":"Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis","volume":"76","author":"Ahmad","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.humimm.2021.09.004_b0080","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1189\/JLB.0309135","article-title":"Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases","volume":"86","author":"Gao","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.humimm.2021.09.004_b0085","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2021.09.004_b0090","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4049\/jimmunol.1800123","article-title":"NK cell-derived IFN-\u03b3 protects against nontuberculous mycobacterial lung infection","volume":"201","author":"Lai","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fimmu.2020.00105","article-title":"Inflammation as a modulator of host susceptibility to pulmonary influenza, pneumococcal, and co-infections","volume":"11","author":"Aguilera","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2020.100737","article-title":"NK cells: a double edge sword against SARS-CoV-2","volume":"77","author":"Masselli","year":"2020","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.humimm.2021.09.004_b0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/imm.13143","article-title":"Tissue-resident innate immunity in the lung","volume":"159","author":"Ardain","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2021.09.004_b0110","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.4049\/jimmunol.137.9.2735","article-title":"Natural killer cells: definition of a cell type rather than a function","volume":"137","author":"Lanier","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0115","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1172\/JCI111794","article-title":"Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes","volume":"75","author":"Hercend","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.humimm.2021.09.004_b0120","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.4049\/jimmunol.131.4.1789","article-title":"Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens","volume":"131","author":"Lanier","year":"1983","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0125","first-page":"3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.humimm.2021.09.004_b0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In search of the \u2018missing self\u2019: MHC molecules and NK cell recognition","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol. Today"},{"key":"10.1016\/j.humimm.2021.09.004_b0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-065X.2006.00457.x","article-title":"Activation, coactivation, and costimulation of resting human natural killer cells","volume":"214","author":"Bryceson","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2021.09.004_b0140","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1126\/science.1103478","article-title":"Natural killer cell signaling pathways","volume":"306","author":"Vivier","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.humimm.2021.09.004_b0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/icb.2010.78","article-title":"Activating and inhibitory receptors of natural killer cells","volume":"89","author":"Pegram","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.humimm.2021.09.004_b0150","series-title":"HLA-E Polymorphisms and NK Cell Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation","author":"Hosseini","year":"2010"},{"key":"10.1016\/j.humimm.2021.09.004_b0155","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/90589","article-title":"New nomenclature for MHC receptors","volume":"2","author":"Andre","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0160","unstructured":"Carrington M, Norman PJ: The KIR gene cluster. National Library of Medicine (U.S.), Vol. 2003. National Center for Biotechnology Information, Bethesda, Md.. 2003 phttp:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=Books."},{"key":"10.1016\/j.humimm.2021.09.004_b0165","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1084\/jem.183.2.645","article-title":"The human leukocyte antigen (HLA)-C-specific \u201cactivatory\u201d or \u201cinhibitory\u201d natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions","volume":"183","author":"Biassoni","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0170","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1002\/eji.1830271203","article-title":"Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules","volume":"27","author":"Biassoni","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0175","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4049\/jimmunol.0904117","article-title":"Cutting edge: NKp80 uses an atypical hemi-ITAM to trigger NK cytotoxicity","volume":"186","author":"Dennehy","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0180","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/eji.200323896","article-title":"Selective cross-talk among natural cytotoxicity receptors in human natural killer cells","volume":"33","author":"Augugliaro","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0185","doi-asserted-by":"crossref","unstructured":"R. Biassoni, Natural killer cell receptors Multichain Immune Recognition Receptor Signaling, Spatiotemporal Organization to Human Disease Series. In : Advances in Experimental Medicine and Biology vol Vol. 640 (A.B. Sigalov, ed.) New York, Springer, 2008, p 35.","DOI":"10.1007\/978-0-387-09789-3_4"},{"key":"10.1016\/j.humimm.2021.09.004_b0190","first-page":"394","article-title":"Induction of B7\u2013H6, a ligand for the natural killer cell\u2013activating receptor NKp30, in inflammatory conditions","volume":"122","author":"Matta","year":"2013","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.humimm.2021.09.004_b0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0966-3274(02)00062-X","article-title":"Natural killer cells and their receptors","volume":"10","author":"Middleton","year":"2002","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03424.x","article-title":"Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease","volume":"149","author":"Boyton","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0205","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molimm.2004.07.031","article-title":"The cell biology of the human natural killer cell CD94\/NKG2A inhibitory receptor","volume":"42","author":"Borrego","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-065X.2006.00460.x","article-title":"Activation and self-tolerance of natural killer cells","volume":"214","author":"Gasser","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2021.09.004_b0215","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.20072525","article-title":"CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence","volume":"205","author":"Petrie","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0220","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.187.5.813","article-title":"Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94\/NKG2 confers protection from natural killer cell-mediated lysis","volume":"187","author":"Borrego","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0225","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2021.09.004_b0230","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.4049\/jimmunol.164.10.5019","article-title":"Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis","volume":"164","author":"Ulbrecht","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0235","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.287.5455.1031","article-title":"Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40","volume":"287","author":"Tomasec","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.humimm.2021.09.004_b0240","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1084\/jem.20020797","article-title":"A signal peptide derived from hsp60 binds HLA-E and interferes with CD94\/NKG2A recognition","volume":"196","author":"Micha\u00eblsson","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0245","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1084\/jem.20020427","article-title":"Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts","volume":"197","author":"Watzl","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0250","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.it.2008.04.007","article-title":"NKG2D ligands: key targets of the immune response","volume":"29","author":"Gonzalez","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0255","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.humimm.2021.09.004_b0260","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0006-291X(03)00714-9","article-title":"ULBP4 is a novel ligand for human NKG2D","volume":"305","author":"Chalupny","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.humimm.2021.09.004_b0265","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1074-7613(01)00095-4","article-title":"ULBPs, novel MHC class I\u2013related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor","volume":"14","author":"Cosman","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2021.09.004_b0270","first-page":"461","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.humimm.2021.09.004_b0275","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ni1524","article-title":"NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway","volume":"8","author":"Horng","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0280","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fimmu.2018.00441","article-title":"NKG2D: a master regulator of immune cell responsiveness","volume":"9","author":"Wensveen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0285","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/cmi.2009.3","article-title":"Cell death mechanisms induced by cytotoxic lymphocytes","volume":"6","author":"Chavez-Galan","year":"2009","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0290","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1084\/jem.173.5.1099","article-title":"Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes","volume":"173","author":"Peters","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0295","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0005-2736(91)90363-D","article-title":"Functional size of complement and perforin pores compared by confocal laser scanning microscopy and fluorescence microphotolysis","volume":"1063","author":"Sauer","year":"1991","journal-title":"BBA"},{"key":"10.1016\/j.humimm.2021.09.004_b0300","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0167-5699(95)80121-9","article-title":"Perforin: structure and function","volume":"16","author":"Liu","year":"1995","journal-title":"Immunol. Today"},{"key":"10.1016\/j.humimm.2021.09.004_b0305","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1074\/jbc.M413303200","article-title":"Calcium-dependent plasma membrane binding and cell lysis by perforin are mediated through its C2 domain: a critical role for aspartate residues 429, 435, 483, and 485 but not 491","volume":"280","author":"Voskoboinik","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2021.09.004_b0310","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.cdd.4402244","article-title":"Mechanisms of granule-dependent killing","volume":"15","author":"Cullen","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.humimm.2021.09.004_b0315","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2172-8-9","article-title":"Expression, processing and transcriptional regulation of granulysin in short-term activated human lymphocytes","volume":"8","author":"Latinovic-Golic","year":"2007","journal-title":"BMC Immunol"},{"key":"10.1016\/j.humimm.2021.09.004_b0320","article-title":"Clinical cancer therapy by NK cells via antibody-dependent cell-mediated cytotoxicity","volume":"2011","author":"Alderson","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.humimm.2021.09.004_b0325","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/77513","article-title":"Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression","volume":"6","author":"Zhang","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0330","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1126\/science.282.5394.1714","article-title":"Regulation of the proinflammatory effects of Fas ligand (CD95L)","volume":"282","author":"Chen","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.humimm.2021.09.004_b0335","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-065X.2008.00737.x","article-title":"Innate immunity to virus infection","volume":"227","author":"Takeuchi","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2021.09.004_b0340","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0345","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.coviro.2011.10.017","article-title":"Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience","volume":"1","author":"Vidal","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.humimm.2021.09.004_b0350","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jaci.2013.07.020","article-title":"Natural killer cell deficiency","volume":"132","author":"Orange","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0355","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJM198906293202605","article-title":"Severe herpesvirus infections in an adolescent without natural killer cells","volume":"320","author":"Biron","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0360","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40121-017-0146-1","article-title":"Infections in cancer patients with solid tumors: a review","volume":"6","author":"Rolston","year":"2017","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.humimm.2021.09.004_b0365","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.172.12.7335","article-title":"Elevated TGF-\u03b21 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients","volume":"172","author":"Lee","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0370","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1158\/0008-5472.CAN-12-1993","article-title":"Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells","volume":"73","author":"Tai","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2021.09.004_b0375","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1172\/JCI74337","article-title":"Cytokine therapy reverses NK cell anergy in MHC-deficient tumors","volume":"124","author":"Ardolino","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.humimm.2021.09.004_b0380","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1245\/s10434-018-6691-3","article-title":"Natural killer cell IFN\u03b3 secretion is profoundly suppressed following colorectal cancer surgery","volume":"25","author":"Angka","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.humimm.2021.09.004_b0385","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.3389\/fmicb.2018.03097","article-title":"Respiratory viral infections in patients with cancer or undergoing hematopoietic cell transplant","volume":"9","author":"Hijano","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.humimm.2021.09.004_b0390","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000503030","article-title":"Innate immune evasion by human respiratory RNA viruses","volume":"12","author":"Kikkert","year":"2020","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.humimm.2021.09.004_b0395","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"O'garra A: type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0400","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1513\/pats.200508-090JS","article-title":"Innate immunity in the lungs","volume":"2","author":"Martin","year":"2005","journal-title":"Proc. Am. Thoracic Soc."},{"key":"10.1016\/j.humimm.2021.09.004_b0405","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cytogfr.2014.11.003","article-title":"NK cells and interferons","volume":"26","author":"Paolini","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.humimm.2021.09.004_b0410","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/biof.107","article-title":"Cytokine regulation of natural killer cell effector functions","volume":"36","author":"Zwirner","year":"2010","journal-title":"BioFactors"},{"key":"10.1016\/j.humimm.2021.09.004_b0415","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.4049\/jimmunol.169.8.4279","article-title":"Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection","volume":"169","author":"Nguyen","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0420","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3389\/fimmu.2017.00930","article-title":"Developmental and functional control of natural killer cells by cytokines","volume":"8","author":"Wu","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0425","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1586\/14787210.6.6.867","article-title":"Natural killer cells in immunodefense against infective agents","volume":"6","author":"Zucchini","year":"2008","journal-title":"Expert Rev. Anti-infective Therapy"},{"key":"10.1016\/j.humimm.2021.09.004_b0430","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fimmu.2016.00166","article-title":"Licensed and unlicensed NK cells: differential roles in cancer and viral control","volume":"7","author":"Tu","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0435","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fimmu.2015.00031","article-title":"NKp44 and natural cytotoxicity receptors as damage-associated molecular pattern recognition receptors","volume":"6","author":"Horton","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0440","doi-asserted-by":"crossref","first-page":"28537","DOI":"10.18632\/oncotarget.5952","article-title":"DNAM-1: would the real natural killer cell please stand up!","volume":"6","author":"Huntington","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.humimm.2021.09.004_b0445","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.4049\/jimmunol.155.5.2306","article-title":"Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes","volume":"155","author":"D'andrea","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0450","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/1074-7613(95)90025-X","article-title":"Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and intracellular domains","volume":"2","author":"Wagtmann","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2021.09.004_b0455","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.7716543","article-title":"Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells","volume":"268","author":"Colonna","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.humimm.2021.09.004_b0460","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer receptors CD94\/NKG2A, B and C","volume":"391","author":"Allan","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2021.09.004_b0465","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1084\/jem.188.10.1841","article-title":"Mouse CD94\/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1b","volume":"188","author":"Vance","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0470","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/icb.2013.99","article-title":"TLR-mediated activation of NK cells and their role in bacterial\/viral immune responses in mammals","volume":"92","author":"Adib-Conquy","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.humimm.2021.09.004_b0475","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1084\/jem.20090168","article-title":"Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection","volume":"206","author":"Orr","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0480","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fimmu.2012.00335","article-title":"Human NK cell lytic granules and regulation of their exocytosis","volume":"3","author":"Krzewski","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0485","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.it.2007.04.001","article-title":"Keeping NK cells in highly regulated antiviral warfare","volume":"28","author":"Lee","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403005623","article-title":"Antitumour immune responses","volume":"5","author":"Mitra","year":"2003","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0495","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","article-title":"Biology of natural killer cells","volume":"47","author":"Trinchieri","year":"1989","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0500","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1365-3083.2002.01053.x","article-title":"NK cells, MHC class I molecules and the missing self","volume":"55","author":"K\u00e4rre","year":"2002","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102561","article-title":"Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH?","author":"Osman","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.humimm.2021.09.004_b0510","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.autrev.2018.10.005","article-title":"Innate immune-responses and their role in driving autoimmunity","volume":"18","author":"Toubi","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.humimm.2021.09.004_b0515","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.exphem.2014.11.007","article-title":"Do human leukocyte antigen E polymorphisms influence graft-versus-leukemia after allogeneic hematopoietic stem cell transplantation?","volume":"43","author":"Hosseini","year":"2015","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.humimm.2021.09.004_b0520","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01512","article-title":"Flattening the COVID-19 curve with natural killer cell based immunotherapies","volume":"11","author":"Market","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0525","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.autrev.2005.04.015","article-title":"NK\u2013DC interaction: on the usefulness of auto-aggression","volume":"4","author":"Marcenaro","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.humimm.2021.09.004_b0530","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3389\/fimmu.2019.01415","article-title":"An historical overview: the discovery of how NK cells can kill enemies, recruit defense troops, and more","volume":"10","author":"Vitale","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0535","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coi.2016.11.003","article-title":"NK cells in host responses to viral infections","volume":"44","author":"Lam","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0540","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1084\/jem.20122220","article-title":"Diverse novel functions of neutrophils in immunity, inflammation, and beyond","volume":"210","author":"M\u00f3csai","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0545","first-page":"710","article-title":"Social networking of human neutrophils within the immune system","volume":"124","author":"Scapini","year":"2014","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.humimm.2021.09.004_b0550","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/intimm\/dxq434","article-title":"Neutrophil activation and survival are modulated by interaction with NK cells","volume":"22","author":"Costantini","year":"2010","journal-title":"Int. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0555","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.4049\/jimmunol.1102002","article-title":"Human NK Cells induce neutrophil apoptosis via an NKp46-and Fas-dependent mechanism","volume":"188","author":"Thor\u00e9n","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0560","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.20111908","article-title":"Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis","volume":"209","author":"Jaeger","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0565","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4049\/jimmunol.1500709","article-title":"TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses","volume":"195","author":"Riise","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0570","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cyto.2013.11.010","article-title":"Neutrophil microparticles modulate cytokine production by natural killer cells","volume":"65","author":"Pliyev","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.humimm.2021.09.004_b0575","doi-asserted-by":"crossref","unstructured":"Amano K, Hirayama M, Azuma E, Iwamoto S, Keida Y, Komada Y: Neutrophils induced licensing of natural killer cells. Mediators Inflamm. 2015;2015.","DOI":"10.1155\/2015\/747680"},{"key":"10.1016\/j.humimm.2021.09.004_b0580","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fimmu.2012.00403","article-title":"Consequences of the crosstalk between monocytes\/macrophages and natural killer cells","volume":"3","author":"Michel","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0585","doi-asserted-by":"crossref","first-page":"16606","DOI":"10.1073\/pnas.0407522101","article-title":"Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs","volume":"101","author":"Ferlazzo","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.humimm.2021.09.004_b0590","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/eji.200425100","article-title":"The small subset of CD56brightCD16\u2013natural killer cells is selectively responsible for both cell proliferation and interferon-\u03b3 production upon interaction with dendritic cells","volume":"34","author":"Vitale","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0595","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20071913","article-title":"IL-15R\u03b1 chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation","volume":"205","author":"Mortier","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0600","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nri956","article-title":"Natural killer cells and dendritic cells: rendezvous in abused tissues","volume":"2","author":"Moretta","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0605","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/imm.12337","article-title":"Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections","volume":"143","author":"Vogel","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2021.09.004_b0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003728","article-title":"Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections","volume":"9","author":"Swiecki","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.humimm.2021.09.004_b0615","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1182\/blood-2005-07-2696","article-title":"Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction","volume":"107","author":"Pende","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2021.09.004_b0620","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1189\/jlb.3A0615-271RR","article-title":"Sensitivity of dendritic cells to NK-mediated lysis depends on the inflammatory environment and is modulated by CD54\/CD226-driven interactions","volume":"100","author":"Smith","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.humimm.2021.09.004_b0625","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4049\/jimmunol.171.5.2366","article-title":"Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function","volume":"171","author":"Mailliard","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0630","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/eji.200636290","article-title":"NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-\u03b3 secretion","volume":"36","author":"Morandi","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0635","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/JVI.03002-13","article-title":"Therapeutic depletion of natural killer cells controls persistent infection","volume":"88","author":"Waggoner","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.humimm.2021.09.004_b0640","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1002\/1521-4141(2001010)31:10<3048::AID-IMMU3048>3.0.CO;2-1","article-title":"NK cell functions restrain T cell responses during viral infections","volume":"31","author":"Su","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0645","first-page":"6593","article-title":"NK cell\u2013mediated killing of target cells triggers robust antigen-specific T cell\u2013mediated and humoral responses","volume":"113","author":"Krebs","year":"2009","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.humimm.2021.09.004_b0650","article-title":"NK cells and their ability to modulate T cells during virus infections","volume":"34","author":"Cook","year":"2014","journal-title":"Crit. Rev.\u2122 in Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41368-020-0074-x","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.humimm.2021.09.004_b0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2021.09.004_b0665","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2021.09.004_b0670","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00607-2020","article-title":"Pathogenesis of COVID-19 from a cell biology perspective","author":"Mason","year":"2020","journal-title":"Eur. Respiratory Soc."},{"key":"10.1016\/j.humimm.2021.09.004_b0675","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/ajcp\/aqaa062","article-title":"Covid-19 autopsies, Oklahoma, USA","volume":"153","author":"Barton","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.humimm.2021.09.004_b0680","article-title":"Natural killer cells in systemic autoinflammatory diseases: a focus on systemic juvenile idiopathic arthritis and macrophage activation syndrome","volume":"10","author":"Vandenhaute","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0685","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0690","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/art.39295","article-title":"Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome","volume":"67","author":"Cifaldi","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.humimm.2021.09.004_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2021.09.004_b0700","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.humimm.2021.09.004_b0705","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.4049\/jimmunol.0901362","article-title":"Intrahepatic IL-10 maintains NKG2A+ Ly49\u2212 liver NK cells in a functionally hyporesponsive state","volume":"184","author":"Lassen","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0710","doi-asserted-by":"crossref","DOI":"10.1172\/JCI138554","article-title":"Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent","author":"Mazzoni","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.humimm.2021.09.004_b0715","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/sji.12022","article-title":"Aberrantly decreased levels of NKG 2D expression in children with Kawasaki disease","volume":"77","author":"Ge","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0720","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.humimm.2021.09.004_b0725","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/0391398819891739","article-title":"Hemoadsorption by extracorporeal cytokine adsorption therapy (CytoSorb\u00ae) in the management of septic shock: a retrospective observational study","volume":"43","author":"Singh","year":"2020","journal-title":"Int. J. Artificial Organs"},{"key":"10.1016\/j.humimm.2021.09.004_b0730","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-\u03b3-related cytokine storm in SARS patients","volume":"75","author":"Huang","year":"2005","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.humimm.2021.09.004_b0735","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0740","unstructured":"Q.-M. Dong, Z.-P. He, H. Zhuang, S.-J. Song, W.-S. Dai, S.-P. Zhang et al.: Dynamics of peripheral blood B lymphocytes and natural killer cells in patients with severe acute respiratory syndrome. Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi 2004;25:695."},{"key":"10.1016\/j.humimm.2021.09.004_b0745","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet. Infect. Dis"},{"key":"10.1016\/j.humimm.2021.09.004_b0750","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0755","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4161\/viru.32077","article-title":"Middle East respiratory syndrome (MERS) A new zoonotic viral pneumonia","volume":"5","author":"Cunha","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.humimm.2021.09.004_b0760","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ijlh.12620","article-title":"Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus","volume":"39","author":"Al-Tawfiq","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.humimm.2021.09.004_b0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.05.009","article-title":"The innate immune system: fighting on the front lines or fanning the flames of COVID-19?","author":"McKechnie","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.humimm.2021.09.004_b0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2021.09.004_b0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.04.018","article-title":"The promise and peril of natural killer cell therapies in pulmonary infection","author":"Rajaram","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2021.09.004_b0780","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"1","author":"Liao","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.humimm.2021.09.004_b0790","doi-asserted-by":"crossref","unstructured":"Y. Zhu, M. Jiang, L. Gao, X. Huang, Single cell analysis of ACE2 expression reveals the potential targets for 2019-nCoV, 2020.","DOI":"10.20944\/preprints202002.0221.v1"},{"key":"10.1016\/j.humimm.2021.09.004_b0795","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1128\/JVI.02340-09","article-title":"Inhibition of human natural killer cell activity by influenza virions and hemagglutinin","volume":"84","author":"Mao","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.humimm.2021.09.004_b0800","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0805","doi-asserted-by":"crossref","unstructured":"J. Carvelli, O. Demaria, F. V\u00e9ly, L. Batista, N.C. Benmansour, J. Fares, et al.: Identification of immune checkpoints in COVID-19. 2020.","DOI":"10.21203\/rs.3.rs-27340\/v1"},{"key":"10.1016\/j.humimm.2021.09.004_b0810","doi-asserted-by":"crossref","unstructured":"A.J. Wilk, A. Rustagi, N.Q. Zhao, J. Roque, G.J. Martinez-Colon, J.L. McKechnie, et al., A single-cell atlas of the peripheral immune response to severe COVID-19. medRxiv 2020.","DOI":"10.1101\/2020.04.17.20069930"},{"key":"10.1016\/j.humimm.2021.09.004_b0815","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andr\u00e9","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2021.09.004_b0820","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41423-019-0224-2","article-title":"Targeting natural killer cells in solid tumors","volume":"16","author":"Habif","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0825","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI45816","article-title":"Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity","volume":"121","author":"Mamessier","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.humimm.2021.09.004_b0830","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s40425-019-0761-3","article-title":"Monalizumab: inhibiting the novel immune checkpoint NKG2A","volume":"7","author":"van Hall","year":"2019","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.humimm.2021.09.004_b0835","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Sem. Immunopathol."},{"key":"10.1016\/j.humimm.2021.09.004_b0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.05.006","article-title":"Host-viral infection maps reveal signatures of severe COVID-19 patients","author":"Bost","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2021.09.004_b0845","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/JVI.01281-09","article-title":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB\/c mice: CD4+ T cells are important in control of SARS-CoV infection","volume":"84","author":"Chen","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.humimm.2021.09.004_b0850","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.humimm.2021.09.004_b0855","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.humimm.2021.09.004_b0860","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/ITT.S202015","article-title":"Cytokine release syndrome: current perspectives","volume":"8","author":"Murthy","year":"2019","journal-title":"ImmunoTargets Therapy"},{"key":"10.1016\/j.humimm.2021.09.004_b0865","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25900","article-title":"High IL-6\/IFN-\u03b3 ratio could be associated with severe disease in COVID-19 patients","author":"Lagunas-Rangel","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.humimm.2021.09.004_b0870","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","author":"Wu","year":"2020","journal-title":"JAMA Internal Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0875","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2021.09.004_b0880","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-08-3712","article-title":"Expansion of highly cytotoxic human natural killer cells for cancer cell therapy","volume":"69","author":"Fujisaki","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2021.09.004_b0885","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1182\/bloodadvances.2018028332","article-title":"First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia","volume":"3","author":"Cooley","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.humimm.2021.09.004_b0890","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3389\/fimmu.2019.01205","article-title":"Cancer immunotherapy based on natural killer cells: current progress and new opportunities","volume":"10","author":"Hu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109777","article-title":"Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents","author":"Yaqinuddin","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.humimm.2021.09.004_b0900","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.leukres.2015.12.002","article-title":"NK cell maturation to CD56(dim) subset associated with high levels of NCRs overrides the inhibitory effect of NKG2A and recovers impaired NK cell cytolytic potential after allogeneic hematopoietic stem cell transplantation","volume":"43","author":"Ghasemzadeh","year":"2016","journal-title":"Leuk. Res."},{"key":"10.1016\/j.humimm.2021.09.004_b0905","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.scr.2017.01.010","article-title":"Ex vivo expansion of CD3(depleted) cord blood-MNCs in the presence of bone marrow stromal cells; an appropriate strategy to provide functional NK cells applicable for cellular therapy","volume":"19","author":"Hosseini","year":"2017","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.humimm.2021.09.004_b0910","first-page":"1","article-title":"NK cells for cancer immunotherapy","author":"Shimasaki","year":"2020","journal-title":"Nat. Rev. Drug Disc."},{"key":"10.1016\/j.humimm.2021.09.004_b0915","unstructured":"I. Celularity, Celularity Announces FDA Clearance of IND Application for CYNK-001 in Coronavirus, First in Cellular Therapy. PR Newswire. Available online at: 4. 2020."},{"key":"10.1016\/j.humimm.2021.09.004_b0920","doi-asserted-by":"crossref","first-page":"11483","DOI":"10.1038\/srep11483","article-title":"CAR-engineered NK cells targeting wild-type EGFR and EGFRvIII enhance killing of glioblastoma and patient-derived glioblastoma stem cells","volume":"5","author":"Han","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2021.09.004_b0925","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0930","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.3389\/fimmu.2019.02741","article-title":"Vaccine-induced antibodies mediate higher antibody-dependent cellular cytotoxicity after interleukin-15 pretreatment of natural killer effector cells","volume":"10","author":"Fisher","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0935","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1067\/mai.2001.119556","article-title":"Expression of IL-15 in inflammatory pulmonary diseases","volume":"108","author":"Muro","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0940","article-title":"Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions","volume":"155143","author":"Noroozi","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.humimm.2021.09.004_b0945","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/infdis\/jiz657","article-title":"Antibody-dependent natural killer cell activation after Ebola vaccination","volume":"223","author":"Wagstaffe","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.humimm.2021.09.004_b0950","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.3389\/fimmu.2019.02875","article-title":"Antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies constrain neutralizing antibody escape pathway","volume":"10","author":"Mielke","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0955","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201731","article-title":"Virus-specific NK cell memory","volume":"218","author":"Sheppard","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2021.09.004_b0960","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ni.3227","article-title":"Antigen-specific NK cell memory in rhesus macaques","volume":"16","author":"Reeves","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2021.09.004_b0965","doi-asserted-by":"crossref","first-page":"14725","DOI":"10.1073\/pnas.1110900108","article-title":"Expansion of a unique CD57+ NKG2Chi natural killer cell subset during acute human cytomegalovirus infection","volume":"108","author":"Lopez-Verg\u00e8s","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.humimm.2021.09.004_b0970","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Gum\u00e1","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2021.09.004_b0975","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4049\/jimmunol.1203034","article-title":"Cutting edge: antibody-dependent memory-like NK cells distinguished by FcR\u03b3 deficiency","volume":"190","author":"Zhang","year":"2013","journal-title":"J. Immunol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885921002305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885921002305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:55:20Z","timestamp":1759319720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885921002305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":195,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0198885921002305"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2021.09.004","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2021.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}